Clinical Studies Sponsored by BIOCAD | 72 results

An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients

Name	NCT Number	Health Conditions in Trial	Clinical Trial Start Date	Study Completion Date	Clinical Trial Study Type
‌ Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA)	NCT06333210	‌ Axial spondyloarthritis	December 25, 2023	2028	Interventional
‌ A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma	NCT06296121	Multiple myeloma	December 21, 2023	2026	Interventional
‌ Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children with Moderate to Severe Plaque Psoriasis	NCT06640517		August 8, 2024	2028	Interventional
‌ Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® As Monotherapy in Subjects with Advanced Melanoma of the Skin	NCT06640530		March 21, 2024	2027	Interventional
‌ An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients with Relapsed/Refractory Multiple Myeloma	NCT06668792		2024	2028	Interventional
‌ Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®	NCT02762799		July 18, 2016	November 11, 2016	Interventional
‌ Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer	NCT03065010	‌ Breast Cancer	2016	2018	Interventional
‌ A Study of BCD-135 in Patients With Advanced Solid Tumors	NCT03464032	Bladder cancer Renal cell carcinoma Melanoma	October 31, 2017	October 31, 2018	Interventional
‌ Phase I Study of BCD-145 (Anti-CTLA-4) in Patients With Unresectable/Metastatic Melanoma	NCT03472027	Melanoma	October 2, 2017	December 4, 2018	Interventional
‌ The Study of PK, PD, Safety of Multiple Intravenous Injections of BCD-066 and Aranesp in Healthy Volunteers	NCT03693950	‌ Healthy	March 28, 2017	July 3, 2017	Interventional
‌ Study of the Pharmacodynamics, Pharmacokinetics, Safety, and Immunogenicity of Single Escalating Doses of BCD-180 in Healthy Volunteers	NCT05407779	‌ Healthy	January 22, 2021	2023	Interventional
‌ Clinical Trial of BCD-148 and Soliris® for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria	NCT04060264	‌ Paroxysmal nocturnal hemoglobinuria	April 4, 2019	December 30, 2020	Interventional
‌ International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis	NCT02762994	Psoriasis	2016	2017	Interventional
‌ Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis	NCT03519243	Anemia	October 24, 2017	December 10, 2018	Interventional
‌ Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C	NCT01740089	Hepatitis Hepatitis C	2011	2013	Interventional
‌ An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients	NCT02103439	Hepatitis Hepatitis C	June 6, 2013	August 26, 2015	Interventional
‌ A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors	NCT03050047	Lung cancer Renal cell carcinoma Melanoma	August 30, 2016	2018	Interventional
‌ The BCD-089 (aIL6R) in Patients With Active Rheumatoid Arthritis	NCT03455842		February 1, 2018	October 22, 2019	Interventional
‌ A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19	NCT04397562	COVID-19	April 29, 2020	August 3, 2020	Interventional
‌ A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of a Single Intravenous Infusion of BCD-178 or Perjeta® in Healthy Volunteers	NCT05738993	‌ Breast Cancer	August 8, 2022	January 31, 2024	Interventional
‌ Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris®	NCT04027803		September 21, 2018	April 7, 2019	Interventional
‌ A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A	NCT06185335		July 26, 2023	2033	Interventional
‌ An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque Psoriasis	NCT03390101		December 26, 2017	January 20, 2022	Interventional
‌ Pharmacokinetics and Pharmacodynamics Study of BCD-066 Compared to Aranesp® in Healthy Volunteers	NCT02506881	‌ Healthy	2013	2014	Interventional
‌ A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries	NCT02368314	Deep vein thrombosis	2015	2015	Interventional